Case Study: Cure SMA achieves accelerated development of novel drug candidates with ShareVault

Cure SMA Leverages ShareVault’s Virtual Data Room to Advance Novel Drug Candidates

Cure SMA, a nonprofit patient‑advocacy group funding research to treat and cure spinal muscular atrophy, faced a cumbersome licensing and diligence process for its drug programs because document sharing relied on email and FTP. That approach offered no central repository, no insight into who viewed materials, no ability to tailor permissions, and an unprofessional, disorganized experience—hindering efforts to re‑engage partners after a program returned to Cure SMA in 2016.

Using ShareVault’s virtual data room, Cure SMA created a secure, organized online repository to share pre‑clinical, clinical and regulatory documents with more than a dozen organizations. The solution provided customizable permissions, user activity tracking, advanced security and a searchable structure, enabling staged IP sharing, faster, more professional diligence and better insight into partner interest—streamlining collaborations and advancing development of novel drug candidates.

Cure SMA

Jill Jarecki

Chief Scientific Officer